EMEdgardo Moreno

Edgardo Moreno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Edgardo Moreno has a total of 154 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Brucella abortus egresses from host cells in infective clusters through an actin-dependent mechanism

    by José Fabio Campos-Godínez, Alejandro Hernández-Saborío, Tiffany Vargas-Moya, Valeria Gómez-Vargas, David Espinoza-Villagra, Ignacio Sandoval, María Paula Rojas-Salas, Melany López-Hernández, Rodrigo Vega-Arce, Reynaldo Pereira-Reyes, et al.

    Brucella abortus is an intracellular pathogen whose cell cycle encompasses attachment, internalization, trafficking, replication, and egress from host cells. Although the intracellular life of Brucella has been extensively studied, the mechanisms underlying its exit from host cells remain unclear. In this work, we expand the knowledge of this intracellular step by observing a significant increase in the formation of Brucella -containing vacuoles with autophagic features (aBCVs) and abundant B. abortus extracellular clusters (BECs) after 72 h of infection. Membrane extensions protruding through actin polymerization were evident in cells at later stages of infection. Purified aBCVs and BECs were similar in size and predominantly acidic. These vacuoles exhibited a compact arrangement of well-ordered bacteria, comprising a heterogeneous population of dead and live bacteria and host components, including LAMP-1 and actin filaments. A proportion of BECs were enclosed within an impermeable host membrane, while others were not. The actin cytoskeleton was implicated in the protrusion of BECs, since modulation of Rho GTPases affected intracellular aBCV formation and the egress of BECs. BECs protruding from cells invaded uninfected cells, initiating a new cycle of infection. The topological structure and function of BECs underscore their significance in the Brucella life cycle as vehicles for bacterial dissemination to host cells and organs. IMPORTANCE: B. abortus is an intracellular pathogen that traffics to the endoplasmic reticulum, where it replicates. However, the mechanisms by which Brucella exits host cells and infects new ones remain poorly understood. Our findings reveal that protruding acidic autophagic-like vesicles containing compact, well-organized Brucella clusters are shed from cells via the GTPase-dependent recruitment of actin filaments. Through this process, the vesicles are impermeable to antibodies and other substances, like antibiotics, and are highly infectious to neighboring cells. This mechanism enhances the understanding of the well-known Brucella stealth strategy to evade the immune system and establish harmful, long-lasting infections.

  • Open Access

    Diagnostic Performance of Rose Bengal, Competitive ELISA, and Native Hapten (NH) Assays in S19 Mass‐Vaccinated Cattle in an Endemic Brucellosis Environment

    by Wilson J. Bonilla-Machado, Andrés Aguilar-Chavarría, Carlos Chacón-Díaz, Elías Barquero-Calvo, Esteban Chaves-Olarte, Caterina Guzmán-Verri, Alexis Sandí-Muñoz, Ignacio Moriyón, José María Blasco, Edgardo Moreno, et al.

    Controlling bovine brucellosis requires reliable diagnostics and effective vaccination strategies. We evaluated the performance of three serological assays—the rose bengal test (RBT), competitive ELISA (cELISA), and agar gel immunodiffusion (AGID) with native hapten (NH)+lipopolysaccharide (LPS) antigen—following Brucella abortus S19 vaccination under different protocols. Serum samples were collected from two cattle populations in Costa Rica: (i) a brucellosis‐free cohort of 25 heifers (Farm 1) vaccinated once with a reduced dose of S19 (5 × 10 9 CFU) via either the conjunctival ( n = 5) or subcutaneous ( n = 20) route, and (ii) a previously vaccinated herd with B. abortus RB51 (Farm 2) of 253 cattle, cleared of Brucella infection by test and slaughter, was then vaccinated with S19 (either 5 × 10 10 or 5 × 10 9 CFU, conjunctival or subcutaneous). All sera were tested by RBT, cELISA, and AGID using standard procedures. In validation with control sera, RBT, cELISA, and AGID NH+LPS each correctly identified all 35 positive and all 35 negative sera, while AGID NH+LPS correctly identified 33 of 35 positive sera and all negative sera. In Farm 1, conjunctival vaccination induced only a transient antibody response: all heifers were seronegative by 7 weeks postvaccination, and none developed NH‐specific precipitin lines. Subcutaneous vaccination produced stronger and longer‐lasting responses: ~20% of animals remained RBT/cELISA‐positive at 1 year (5% at 2 years), though none reacted to NH. In Farm 2, S19 vaccination elicited sustained RBT and cELISA seropositivity, especially after subcutaneous administration. About 5% of animals developed NH‐specific precipitin lines over time, consistent with an anamnestic response to residual infection. These findings show that vaccination route affects serological outcomes: conjunctival S19 vaccination yields minimal long‐term interference, while subcutaneous vaccination prolongs seropositivity. The AGID NH+LPS test helped identify actively infected animals in vaccinated herds. We recommend S19 mass vaccination via the conjunctival route and caution against using cELISA as a routine confirmatory test following RBT in endemic settings.

  • Open Access

    Investigations on infections caused by new Brucella species in neotropical forests

    by Anne Keriel, Theo Pastre, Betty Rouaisnel-Boudra, Jean-Philippe Lavigne, Maylis Douine, Loïc Epelboin, Benoit De Thoisy, Anne Lavergne, Damien Donato, Claire Ponsart, et al.

    Brucella amazoniensis is a recently discovered species represented by several isolates from humans (French Guiana, Brazil and USA) and a cow (Texas, USA). Most human cases had close contact with local wildlife; our current hypothesis is thus that some of these animals could serve as a reservoir for this species. B. amazoniensis seems also genetically linked to B. nosferati, another new species concomitantly isolated from hematophagous bats (Costa Rica), and to B. neotomae, a species isolated in USA (rodents) and Costa Rica (humans). This presentation will provide an update about the integrative (so called “One Health”) investigations currently performed through an international partnership involving scientists, health professionals, veterinarians and ecologists from France, French Guiana and Costa Rica. It aims at characterizing these emerging pathogens and identifying the transmission dynamics of brucellosis in the complex ecosystems of neotropical forests. This will improve the understanding and management of brucellosis in this region of the world. Molecular epidemiology could also provide insights into the evolutionary history of this genus.

  • Open Access

    The Brucella genomic origami: How bacteria without plasmids or external recombination evolve and adapt to their intracellular niche

    by Edgardo Moreno

    A comprehensive understanding of Brucella genomic evolution requires the integration of multiple analytical scales, each offering distinct resolutions to capture fine-level mutations and broad structural modifications. Most evolutionary and pathophysiological studies have focused on single-nucleotide polymorphisms and gene-level mutations to elucidate the biogenesis and dynamics of Brucella organisms. In contrast, large-scale genomic rearrangements have received comparatively less attention. This presentation explores the evolution of Brucella genomic architectures, emphasizing the secondary modifications of the chromosomes and chromids, which have profoundly impacted gene expression and bacterial evolution. Examines how internal genomic rearrangement mechanisms and the spatial organization of multiple replicons in bacteria that gave up plasmids and for eons have avoided external recombination have adapted and evolved. Comparative analyses of phylogenetically related Brucella strains with distinct genomic rearrangements will illustrate these evolutionary and adaptive mechanisms. As a case study, the loss of motility in Brucella will be examined as a strategic adaptation linked to the restructuring of replicons and specialization within specific ecological niches.

  • Open Access

    Brucella abortus egresses from host cells in infective clumps through an actin-dependent mechanism

    by Jose Fabio Campos-Godínez, Alejandro Hernández-Saborío, Tiffany Vargas-Moya, Valeria Gómez-Vargas, David Espinoza-Villagra, Ignacio Sandoval, María Paula Rojas-Salas, Melany López-Hernández, Rodrigo Vega-Arce, Reynaldo Pereira-Reyes, et al.

    Brucella abortus is an intracellular pathogen whose cell cycle encompasses attachment, internalization, trafficking, replication, and egress from cells. While the intracellular life of Brucella has been extensively studied, the mechanisms underlying its exit from host cells are still unclear. In this work, we observed a significant increase in the formation of B. abortus containing vacuoles intracellular clumps (BCVIC) and abundant B. abortus containing vacuoles-derived extracellular clumps (BCVEC) after 72 h of infection. Membrane extensions protruding through the polymerization of actin filaments were evident in cells at later stages of infection. Purified BCVIC and BCVEC were of similar sizes and predominantly acidic. These vacuoles exhibited a compact arrangement of well-ordered bacteria, comprised of a heterogeneous population of dead and live bacteria and host components LAMP-1 and actin filaments. A proportion of BCVEC were naked, while others were enclosed within an impermeable host membrane. The actin cytoskeleton was implicated in the protrusion of BCVEC since the modulation of Rho GTPases affected the egress of BCVEC. The BCVEC protruding from cells were capable of invading non-infected cells, initiating a new cycle of infection. The topological structure and function of BCVEC underscore their significance in the Brucella life cycle as vehicles for bacterial dissemination to host cells and organs. Importance: B. abortus is an intracellular pathogen that traffics to the endoplasmic reticulum, where it replicates. However, the mechanisms by which Brucella exits host cells and infects new ones are not fully understood. We found that protruding acidic autophagic-like vesicles containing compact, well-organized Brucella clusters are shed from cells via GTPase and actin filament recruitment. Through this process, the vesicles are impermeable to antibodies and other substances, like antibiotics, and are highly infectious to neighboring cells. This previously unreported mechanism enhances understanding of the well-known Brucella stealth strategy to evade the immune system and establish harmful, long-lasting infections.


  • Open Access

    Cell-to-cell transmission of Brucella abortus

    by José F. Campos-Godínez, Carlos Chacón-Díaz, Edgardo Moreno, Esteban Chaves-Olarte, Pamela Altamirano-Silva

    Brucella abortus is a persistent intracellular pathogen capable of evading early immune responses. To explore the mechanism of exit of this bacterium, we monitored Brucella infection by live cell imaging for up to 100 hours. This approach uncovered various modes of bacterial spreading, including individual organisms, bacteria-containing vacuoles, and direct transmission between cells (called cell-to-cell transmission), each fueling new infections. This dissemination occurred regardless of antibiotic presence in the extracellular milieu. While receptor blockade using heparin suppressed free bacterial infections, it promoted cell-to-cell transmission, dependent on cell density. Cells participating in intercellular transmission survived longer than their non-infected counterparts. These observations underscore the adaptability of Brucella for propagating across diverse conditions. Importance: The intracellular life cycle of pathogenic bacteria encompasses adhesion, invasion, intracellular replication, and eventual exit from host cells. The exit phase is a critical step for pathogen persistence and dissemination to new hosts. Despite its relevance, the egress mechanisms of Brucella spp. remain largely unexplored. In this study, we describe three distinct modes of Brucella abortus exit: individual bacteria, bacterial clumps, and through direct cell-to-cell transmission. The latter may facilitate immune evasion by bypassing extracellular exposure, thereby contributing to the stealthy survival strategy of Brucella . The presence of multiple egress mechanisms suggests that B. abortus tailors its exit strategies according to its intracellular biogenesis and environmental cues.These findings not only advance our understanding of Brucella pathogenesis but also highlight potential avenues for targeting bacterial dissemination and persistence.


  • Open Access

    Reactivation of hidden-latent Brucella infection after doxycycline and streptomycin treatment in mice

    by Eugenia Sancho-Sánchez, Kimberly García-Arteaga, Fabio Granados-Chinchilla, Graciela Artavia, Alejandro Alfaro-Alarcón, Andrés Villalobos-Villalobos, Laura Bouza-Mora, Marcela Suárez-Esquivel, Carlos Chacón-Díaz, Caterina Guzmán-Verri, et al.

    Brucellosis has therapeutic challenges due to 3%–15% relapses/therapeutic failures (R/TF) after antibiotic treatment. Therefore, determining the antibiotic concentration in tissues, the physiopathological parameters, and the R/TF after treatment is relevant. After exploring different antibiotic quantities, we found that a combined dose of 100 µg/g of doxycycline (for 45 days) and 7.5 µg/g of streptomycin (for 14 days), respectively, achieved therapeutic levels of more than fourfold minimum inhibitory concentrations (MICs) against Brucella abortus in the spleen, liver, bone marrow, and plasma of mice, causing minimal pathophysiological effects. After 30 days of infection, mice received antibiotics, and hematological, histopathological, biochemical, and immunological analyses were performed. After antibiotic therapy, the pathological, hematological, immunological, and physiological profiles paralleled those described in human brucellosis. Treatment lowered antibody titers, reduced proinflammatory cytokines, and reduced inflammation in the target organs for a protracted period. No bacteria were detected in tissues 8 weeks after treatment, suggesting complete recovery. However, despite high doxycycline and streptomycin concentrations in tissues, relapses appeared in 100% of the animals after 182 days post-infection, estimated by the bacterial counts and PCR from organs. This proportion contrasts with the 15% R/TF observed in humans after antibiotic treatments. None of the B. abortus isolated from relapses showed augmented MICs or mutations coding for antibiotic resistance in chromosomal-relevant regions. We discuss whether our findings constitute a general phenomenon or differences in the exhaustive screening method for bacteria detection related to the murine model. Along these lines, we envision likely mechanisms of bacterial persistence in tissues after antibiotic treatment.


  • Why are Latin American countries in the limbo of open-access scientific publications?

    by Max Chavarría, Bruno Lomonte, José María Gutiérrez, Edgardo Moreno, Alice L Pérez

    Open Access (OA) model in scientific journals has brought about a range of benefits in terms of information accessibility. However, the high costs associated with Article Processing Charges (APCs) have posed a significant challenge for many scientists, leaving them in a ‘limbo’, where their ability to publish in reputable journals is contingent upon their financial capacity. Here, we intend to highlight the challenges faced by Latin American scientists that have arisen as a direct consequence of the implementation of the OA, specifically: (i) difficulties in disseminating our scientific work due to the impossibility of covering the high APCs imposed by journals, and (ii) the strong emergence and consolidation in our region of publishers with predatory practices. We urge the scientific community to establish policies that contribute to equity in OA models and to defend the right of Latin American scientists not only to read science freely but also to be read.


  • Open Access

    A sensor histidine kinase from a plant-endosymbiont bacterium restores the virulence of a mammalian intracellular pathogen

    by Esteban Chaves-Olarte, Jazmín Meza-Torres, Fabiola Herrera-Rodríguez, Esteban Lizano-González, Marcela Suárez-Esquivel, Kate S. Baker, Olga Rivas-Solano, Nazareth Ruiz-Villalobos, Fabián Villalta-Romero, Hai-Ping Cheng, et al.

  • Open Access

    A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts

    by J. M. Blasco, E. Moreno, P. M. Muñoz, R. Conde-Álvarez, I. Moriyón

    Cattle brucellosis is a severe zoonosis of worldwide distribution caused byBrucella abortusandB. melitensis. In some countries with appropriate infrastructure, animal tagging and movement control, eradication was possible through efficient diagnosis and vaccination withB. abortusS19, usually combined with test-and-slaughter (T/S). Although S19 elicits anti-smooth lipopolysaccharide antibodies that may interfere in the differentiation of infected and vaccinated animals (DIVA), this issue is minimized using appropriate S19 vaccination protocols and irrelevant when high-prevalence makes mass vaccination necessary or when eradication requisites are not met. However, S19 has been broadly replaced by vaccine RB51 (a rifampin-resistant rough mutant) as it is widely accepted that is DIVA, safe and as protective as S19. These RB51 properties are critically reviewed here using the evidence accumulated in the last 35 years. Controlled experiments and field evidence shows that RB51 interferes in immunosorbent assays (iELISA, cELISA and others) and in complement fixation, issues accentuated by revaccinating animals previously immunized with RB51 or S19. Moreover, contacts with virulent brucellae elicit anti-smooth lipopolysaccharide antibodies in RB51 vaccinated animals. Thus, accepting that RB51 is truly DIVA results in extended diagnostic confusions and, when combined with T/S, unnecessary over-culling. Studies supporting the safety of RB51 are flawed and, on the contrary, there is solid evidence that RB51 is excreted in milk and abortifacient in pregnant animals, thus being released in abortions and vaginal fluids. These problems are accentuated by the RB51 virulence in humans, lack diagnostic serological tests detecting these infections and RB51 rifampicin resistance. In controlled experiments, protection by RB51 compares unfavorably with S19 and lasts less than four years with no evidence that RB51-revaccination bolsters immunity, and field studies reporting its usefulness are flawed. There is no evidence that RB51 protects cattle againstB. melitensis,infection common when raised together with small ruminants. Finally, data acumulated during cattle brucellosis eradication in Spain shows that S19-T/S is far more efficacious than RB51-T/S, which does not differ from T/S alone. We conclude that the assumption that RB51 is DIVA, safe, and efficaceous results from the uncritical repetition of imperfectly examined evidence, and advise against its use.